These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
118 related items for PubMed ID: 9072321
1. Distinct expression of transforming growth factor-beta receptor subtypes on vascular smooth muscle cells from spontaneously hypertensive rats and Wistar-Kyoto rats. Fukuda N, Kubo A, Izumi Y, Soma M, Kanmatsuse K. Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S120-2. PubMed ID: 9072321 [Abstract] [Full Text] [Related]
2. Characteristics and expression of transforming growth factor-beta receptor subtypes on vascular smooth muscle cells from spontaneously hypertensive rats. Fukuda N, Kubo A, Izumi Y, Soma M, Kanmatsuse K. J Hypertens; 1995 Aug; 13(8):831-7. PubMed ID: 8557960 [Abstract] [Full Text] [Related]
7. Differences in growth characteristics of vascular smooth muscle from spontaneously hypertensive and Wistar-Kyoto rats are growth factor dependent. Saltis J, Agrotis A, Bobik A. J Hypertens; 1993 Jun; 11(6):629-37. PubMed ID: 8397242 [Abstract] [Full Text] [Related]
8. Low dose of eicosapentaenoic acid inhibits the exaggerated growth of vascular smooth muscle cells from spontaneously hypertensive rats through suppression of transforming growth factor-beta. Nakayama M, Fukuda N, Watanabe Y, Soma M, Hu WY, Kishioka H, Satoh C, Kubo A, Kanmatsuse K. J Hypertens; 1999 Oct; 17(10):1421-30. PubMed ID: 10526902 [Abstract] [Full Text] [Related]
9. Effects of the L- and N-type calcium channel blocker cilnidipine on growth of vascular smooth muscle cells from spontaneously hypertensive rats. Hu WY, Fukuda N, Su JZ, Kanmatsuse K. J Cardiovasc Pharmacol; 2001 Sep; 38(3):450-9. PubMed ID: 11486249 [Abstract] [Full Text] [Related]
16. Inhibitory effect of a novel angiotensin II type 1 receptor antagonist RNH-6270 on growth of vascular smooth muscle cells from spontaneously hypertensive rats: different anti-proliferative effect to angiotensin-converting enzyme inhibitor. Teng J, Fukuda N, Suzuki R, Takagi H, Ikeda Y, Tahira Y, Kanmatsuse K. J Cardiovasc Pharmacol; 2002 Feb; 39(2):161-71. PubMed ID: 11791001 [Abstract] [Full Text] [Related]